Randomized, two-way, two- period, single oral dose, open- label, crossover, bioequivalence study to compare Diclofenac Potassium powder for oral solution (50 mg diclofenac potassium) manufactured by Riyadh Pharma versus Catafast® powder for oral solution (50 mg diclofenac potassium) manufactured by Mipharm S.p.A., in healthy subjects under fasting condition.
2020-07-04
عنوان الدراسة
Randomized, two-way, two- period, single oral dose, open- label, crossover, bioequivalence study to compare Diclofenac Potassium powder for oral solution (50 mg diclofenac potassium) manufactured by Riyadh Pharma versus Catafast® powder for oral solution (50 mg diclofenac potassium) manufactured by Mipharm S.p.A., in healthy subjects under fasting condition.
داعم الدراسة
Saudi Ajal
دواء الدراسة
DICLOFENAC POTASSIUM
رقم بروتوكول الدراسة
42856
حالة الدراسة
Completed
موقع الدراسة
Saudi Ajal
مرحلة الدراسة
BE
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。